Home Cart 0 Sign in  
X

[ CAS No. 39270-39-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 39270-39-8
Chemical Structure| 39270-39-8
Chemical Structure| 39270-39-8
Structure of 39270-39-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 39270-39-8 ]

Related Doc. of [ 39270-39-8 ]

Alternatived Products of [ 39270-39-8 ]

Product Details of [ 39270-39-8 ]

CAS No. :39270-39-8 MDL No. :MFCD01317581
Formula : C9H10O3 Boiling Point : -
Linear Structure Formula :- InChI Key :FFLHNBGNAWYMRH-UHFFFAOYSA-N
M.W : 166.17 Pubchem ID :2776174
Synonyms :

Calculated chemistry of [ 39270-39-8 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 43.44
TPSA : 38.69 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.64 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.05
Log Po/w (XLOGP3) : 0.95
Log Po/w (WLOGP) : 0.8
Log Po/w (MLOGP) : 0.52
Log Po/w (SILICOS-IT) : 1.99
Consensus Log Po/w : 1.26

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.77
Solubility : 2.8 mg/ml ; 0.0169 mol/l
Class : Very soluble
Log S (Ali) : -1.35
Solubility : 7.43 mg/ml ; 0.0447 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.25
Solubility : 0.932 mg/ml ; 0.00561 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.12

Safety of [ 39270-39-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 39270-39-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 39270-39-8 ]
  • Downstream synthetic route of [ 39270-39-8 ]

[ 39270-39-8 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 39270-39-8 ]
  • [ 26309-99-9 ]
YieldReaction ConditionsOperation in experiment
12 g at 20℃; for 0.166667 h; A mixture of (2,3-dihydro-benzo[1,4]dioxin-6-yl)methanol (10.6 g) in SOCl2 (10 mL) was stirred at room temperature for 10 min and then poured into ice-water.
The organic layer was separated and the aqueous phase was extracted with dichloromethane (50 mL*3).
The combined organic layers were washed with NaHCO3 (sat solution), water and brine, dried over Na2SO4 and concentrated to dryness to obtain 6-chloromethyl-2,3-dihydro-benzo[1,4]dioxine (12 g, 88percent over two steps), which was used directly in next step.
Reference: [1] Patent: US2011/98311, 2011, A1,
[2] Tetrahedron, 2001, vol. 57, # 39, p. 8297 - 8303
[3] Patent: US2007/244159, 2007, A1, . Location in patent: Page/Page column 103-104
[4] Patent: US2015/231142, 2015, A1, . Location in patent: Paragraph 1628
[5] Patent: WO2008/141119, 2008, A2, . Location in patent: Page/Page column 76-77
  • 2
  • [ 39270-39-8 ]
  • [ 4442-54-0 ]
Reference: [1] Green Chemistry, 2018, vol. 20, # 13, p. 3038 - 3043
  • 3
  • [ 29668-44-8 ]
  • [ 39270-39-8 ]
YieldReaction ConditionsOperation in experiment
97%
Stage #1: With sodium tetrahydroborate In ethanol at 0 - 20℃; for 1 h;
Stage #2: With water In ethanol
2,3-Dihydro-benzo [1, 4] dioxine-6-carbaldehyde [RN 29668-44-8] (3.04g, 18. 54mmol) was dissolved in ethanol (lOOmL) and cooled to 0°C. To the resulting solution was added sodium borohydride (1. 41g, 37. 07mmol). The resulting slurry was stirred at room temperature for 1 hour and then quenched with water (lOmL) before being concentrated to dryness under reduced pressure. The residue was partitioned between a 5percent aqueous solution of sodium hydrogen carbonate (20mL) and dichloromethane (2x50mL). The organic phases were combined and dried over magnesium sulfate then evaporated under reduced pressure to provide and oil which was purified on silica gel using a dichloromethane and methanol solvent gradient. This provided the desired product as a colourless oil (3. 00g, 97percent).
95% at 0℃; for 0.5 h; (2,3-Dihydrobenzo[b][l,4]dioxin-6-yl)methanol. To a solution of 2,3- dihydrobenzo[b][l,4]dioxine-6-carbaldehyde (TCI America Laboratory Chemicals B2019) (20 g, 0.12 mol) in MeOH (400 mL) at 0 0C was added NaBH4 (14 g, 0.36 mol) in portions. After stirring at 0 0C for 30 minutes, the mixture was neutralized to pH = 7 by addition of 2 M aqueous HCl. The MeOH was removed under reduced pressure, and the residue was extracted with DCM (2 x 200 mL). The combined organic layers were concentrated under reduced pressure to afford (2,3-dihydrobenzo[b][l,4]dioxin-6- yl)methanol (19 g, 95 percent).
Reference: [1] Patent: WO2003/87098, 2003, A1, . Location in patent: Page/Page column 43
[2] Patent: WO2010/83246, 2010, A1, . Location in patent: Page/Page column 149-150
[3] Australian Journal of Chemistry, 1984, vol. 37, # 4, p. 893 - 901
[4] Chemical Communications (Cambridge, United Kingdom), 2018, vol. 54, # 83, p. 11805 - 11808
[5] Tetrahedron, 2001, vol. 57, # 39, p. 8297 - 8303
[6] Journal of the American Chemical Society, 2002, vol. 124, # 34, p. 10071 - 10082
[7] European Journal of Medicinal Chemistry, 2012, vol. 55, p. 125 - 136
[8] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 18, p. 5971 - 5975
[9] Molecules, 2013, vol. 18, # 4, p. 3872 - 3893
[10] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 21, p. 5626 - 5632
  • 4
  • [ 20825-87-0 ]
  • [ 39270-39-8 ]
YieldReaction ConditionsOperation in experiment
10.6 g With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 11 h; Inert atmosphere (2,3-Dihydro-benzo[1,4]dioxin-6-yl)-methanol
To a suspension of LiAlH4 (2.8 g, 74 mmol) in THF (20 mL) was added dropwise a solution of 2,3-dihydro-benzo[1,4]dioxine-6-carboxylic acid ethyl ester (15 g, 72 mmol) in THF (10 mL) at 0° C. under N2.
The mixture was stirred at room temperature for 11 h and then quenched carefully with addition of water (2.8 mL) and NaOH (10percent, 28 mL) with cooling.
The precipitated solid was filtered off and the filtrate was evaporated to dryness to obtain (2,3-dihydro-benzo[1,4]dioxin-6-yl)-methanol (10.6 g).
1H NMR (300 MHz, DMSO-d6) δ 6.73-6.78 (m, 3H), 5.02 (t, J=5.7 Hz, 1H), 4.34 (d, J=6.0 Hz, 2H), 4.17-4.20 (m, 4H).
Reference: [1] Synthetic Communications, 2001, vol. 31, # 12, p. 1875 - 1877
[2] Patent: US2007/244159, 2007, A1, . Location in patent: Page/Page column 103
[3] Patent: US2011/98311, 2011, A1,
[4] Patent: US2015/231142, 2015, A1, . Location in patent: Paragraph 1627
[5] Patent: WO2008/141119, 2008, A2, . Location in patent: Page/Page column 76
  • 5
  • [ 4442-54-0 ]
  • [ 39270-39-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 4, p. 1033 - 1058
  • 6
  • [ 3943-89-3 ]
  • [ 39270-39-8 ]
Reference: [1] Patent: US2011/98311, 2011, A1,
[2] Patent: US2015/231142, 2015, A1,
[3] Patent: WO2008/141119, 2008, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 39270-39-8 ]

Alcohols

Chemical Structure| 93-03-8

[ 93-03-8 ]

(3,4-Dimethoxyphenyl)methanol

Similarity: 0.94

Chemical Structure| 57371-44-5

[ 57371-44-5 ]

3-(4-(Benzyloxy)-3-methoxyphenyl)propan-1-ol

Similarity: 0.90

Chemical Structure| 13826-35-2

[ 13826-35-2 ]

(3-Phenoxyphenyl)methanol

Similarity: 0.89

Chemical Structure| 13807-89-1

[ 13807-89-1 ]

2-((4-Methoxybenzyl)oxy)ethanol

Similarity: 0.89

Chemical Structure| 15149-10-7

[ 15149-10-7 ]

2-(p-Tolyloxy)ethanol

Similarity: 0.89

Related Parent Nucleus of
[ 39270-39-8 ]

Benzodioxans

Chemical Structure| 274910-19-9

[ 274910-19-9 ]

(2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)methanol

Similarity: 0.81

Chemical Structure| 29668-44-8

[ 29668-44-8 ]

2,3-Dihydrobenzo[b][1,4]dioxine-6-carbaldehyde

Similarity: 0.79

Chemical Structure| 79440-34-9

[ 79440-34-9 ]

6-(Bromomethyl)-2,3-dihydrobenzo[b][1,4]dioxine

Similarity: 0.77

Chemical Structure| 4442-54-0

[ 4442-54-0 ]

2,3-Dihydro-1,4-benzodioxine-6-carboxylic acid

Similarity: 0.77

Chemical Structure| 31127-39-6

[ 31127-39-6 ]

2,3-Dihydrobenzo[b][1,4]dioxine-6-carbaldehyde oxime

Similarity: 0.72